Alzheimer's Disease (AD) and Related Disorders Clinical Trial
— MusicAlzheimerOfficial title:
Non-drug Taken Charge of Alzheimer's Disease: Profit Musical Activities
Cares of Alzheimer's disease (AD) and related disorders are presenting a real public health challenge. Because of the limited effectiveness of pharmacological treatments, there is a growing interest in care approach based on nonpharmacological treatments, such as musical interventions. Several lines of evidence suggest that musical interventions could improve behaviour, emotion and even cognition in patients with AD. However, very few studies respond to the methodological constraints required for clinical controlled trials carried out in well selected groups of patients. The efficiency of such care approaches is not scientifically proved yet and the impact of musical interventions has rarely been compared to another pleasant intervention, leaving open the question about the specific benefits of music in patients with dementia. The main goal of this research project is to demonstrate short and longer-term efficiencies and the specificity of musical interventions in dementia by investigating their effects not only in patients but also in familial and professional caregivers.
Status | Completed |
Enrollment | 150 |
Est. completion date | June 2015 |
Est. primary completion date | June 2015 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 60 Years to 99 Years |
Eligibility |
Inclusion Criteria: - Older People and francophones living in institutions - Presenting a cortical degenerative disease - Male or female - Age 60 to 99 years - French Mother tongue - People enjoying a social security scheme - Patient Participation Agreement and of the person of trust or his legal representative. Exclusion Criteria: - Patients without cortical degenerative disease - Patients with uncorrected profound hearing loss - Not affiliated with a social security scheme Patients . - Patients refusing to participate in the study or with the agreement of the person of trust or his legal representative was not obtained - Patient protected by law |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Double Blind (Caregiver, Outcomes Assessor), Primary Purpose: Supportive Care
Country | Name | City | State |
---|---|---|---|
France | Chu de Reims | Reims |
Lead Sponsor | Collaborator |
---|---|
CHU de Reims |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Overall score in the Neuropsychiatric Inventory | up to 11 weeks | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02164643 -
Longitudinal Study of Brain Amyloid imaGing in MEMENTO
|
Phase 3 | |
Completed |
NCT01926249 -
A Cohort of Outpatients From French Research Memory Centers in Order to Improve Knowledge on Alzheimer's Disease and Related Disorders
|